Loading…

Ivosidenib for the Treatment of IDH1-mutant Glioma, Grades 2 to 4: Tolerability, Predictors of Response, and Outcomes

Saved in:
Bibliographic Details
Published in:Neuro-oncology advances 2024-12
Main Authors: Lanman, Tyler A, Youssef, Gilbert, Huang, Raymond, Rahman, Rifaquat, DeSalvo, Matthew, Flood, Thomas, Hassanzadeh, Elmira, Lang, Min, Lauer, Jason, Potter, Christopher, Jiao, Albert, Pan, Ian, Cahill, Daniel P, Lan, Zhou, Ospina, Juan Pablo, Nakhate, Vihang, Stec, Natalie E, Shi, Diana, Bi, Wenya Linda, McBrayer, Samuel K, Arrillaga-Romany, Isabel, Lee, Eudocia Q, Chukwueke, Ugonma N, Nayak, Lakshmi, Forst, Deborah A, Gerstner, Elizabeth R, Jordan, Justin T, Dietrich, Jorg, Miller, Julie, Batchelor, Tracy T, Reardon, David A, Wen, Patrick Y, Gonzalez Castro, L Nicolas
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2632-2498
2632-2498
DOI:10.1093/noajnl/vdae227